PD Dr. Benjamin Hofner, Head of the department for Biostatistics at the Paul-Ehrlich-Institute Langen, Federal Institute for Vaccines and Biomedicines; Adjunct Lecturer at the University Erlangen-Nuremberg.
The lecture will be held in German.
Topic: „Statistik in Zeiten von Corona – Der komplexe Weg zur Zulassung eines Impfstoffes“
Time: Sunday, March, 14th, 2021, 18.00h-19.30h
PD Dr Benjamin Hofner is Head of the Section Biostatistics at the Paul-Ehrlich-Institute, the German Federal Institute for Vaccines and Biomedicines. He provides input to the Biostatistics Working Party (BSWP) of the European Medicines Agency (EMA). He is member in several BSWP task forces, including a group working on guidance for studies for the treatment and prevention of COVID-19.
Dr Hofner graduated in Statistics from the LMU Munich in 2008. In 2011 he obtained his PhD in Statistics from the LMU Munich for his work on statistical approaches to machine learning. In 2018 he received his Venia Legendi (“Privatdozent”) in Biostatistics from the University Erlangen-Nuremberg.
Dr Hofner’s current research interests mainly focus on innovative clinical trial designs and other statistical issues in the field of “regulatory biostatistics”. He is Task Lead in the EU-funded IMI project EU-PEARL on patient-centric platform trials and Work Package Lead in the IMI project COMBINE on anti-microbial resistance. Besides his duties at the Paul-Ehrlich-Institute, he is Adjunct Lecturer for Biostatistics at the medical school of the University Erlangen-Nuremberg.